English  |  正體中文  |  简体中文  |  Items with full text/Total items : 21921/27947 (78%)
Visitors : 4217036      Online Users : 419
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: http://140.128.103.80:8080/handle/310901/9139


    Title: Elevated titer and seropositivity of the antibody to human papillomavirus E6 protein in cervical cancer patients
    Other Titles: 子宮頸癌病患血清中具有高效價與高血清陽性率的抗人類乳突瘤病毒E6抗體
    Authors: 郭展延;李致叡;鄭瓊姬;張智翔;陳子和;蔡玉真;黃光裕
    Kuol, Chan-Yen;Lee, Chih-Jui;Cheng,Chiung-Chi;Chang,Chih-Hsiang;Chen, Tze-Ho;Tsai, Yu-Chen;Hwang, Guang-Yuh
    Contributors: 東海大學理學院
    Keywords: Human Papilloma Viruses (HPV), Cervical Cancer, anti-E6 antibody
    Date: 2010-11-01
    Issue Date: 2011-06-16T03:59:49Z (UTC)
    Publisher: 台中市:東海大學
    Abstract: Development of cervical cancer is associated with human papillomavirus (HPV)
    infection. However, data on comparison among the antibodies of anti-E6, anti-E7,
    and anti-L1 in the sera of patients with cervical cancer or HPV infection are very
    limited. In this study, we examined the expression of HPV-18 nonstructural proteins
    E6, E7, and the major capsid L1 protein in tissues from 25 patients with cervical cancer
    at stages ranging from Ib to IIa, based on the FIGO staging system. We also used
    ELISA to assess the antibodies against the HPV-18 E6, E7, and L1 proteins in the sera
    of these patients (patients) and in the sera of 20 healthy individuals (normal). Western
    blotting and immunohistochemical staining of these tissues confirmed the presence of
    the E6, E7, and L1 proteins. As compared to the normal controls, the patients’ sera
    showed higher binding of the anti-E6, anti-E7, and anti-L1 antibodies. The anti-E6
    and anti-E7 antibodies showed stronger binding than anti-L1 among all the 25 sera
    samples tested. The seropositive percentage of anti-E6 (88%) was higher than that of
    anti-E7 (32%) and anti-L1 (48%). These data suggest that elevated titer and
    seropositivity of the antibody to human papillomavirus E6 protein in the sera of
    cervical cancer patients. Interestingly, we also found that the 19 patients who
    indicated as anti-E6 seropositivity had a lower 5-year cumulate survival outcome.
    Relation: 東海科學第13卷, p.1-16
    Appears in Collections:[理學院] (校內出版品)東海科學

    Files in This Item:

    File SizeFormat
    13-1.pdf419KbAdobe PDF932View/Open


    All items in THUIR are protected by copyright, with all rights reserved.


    本網站之東海大學機構典藏數位內容,無償提供學術研究與公眾教育等公益性使用,惟仍請適度,合理使用本網站之內容,以尊重著作權人之權益。商業上之利用,則請先取得著作權人之授權。

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback